187 related articles for article (PubMed ID: 31900502)
1. Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases.
Coskun Benlidayi I
Rheumatol Int; 2020 Jun; 40(6):849-858. PubMed ID: 31900502
[TBL] [Abstract][Full Text] [Related]
2. Review of publications evaluating opioid use in patients with inflammatory rheumatic disease.
Anastasiou C; Yazdany J
Curr Opin Rheumatol; 2022 Mar; 34(2):95-102. PubMed ID: 35044328
[TBL] [Abstract][Full Text] [Related]
3. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity.
Haliloglu S; Carlioglu A; Akdeniz D; Karaaslan Y; Kosar A
Rheumatol Int; 2014 Sep; 34(9):1275-80. PubMed ID: 24589726
[TBL] [Abstract][Full Text] [Related]
4. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
5. Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment.
Mease PJ
Curr Opin Rheumatol; 2017 Jul; 29(4):304-310. PubMed ID: 28394827
[TBL] [Abstract][Full Text] [Related]
6. How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) - A pharmacological review.
Gérard B; Bailly F; Trouvin AP
Joint Bone Spine; 2024 Jan; 91(1):105624. PubMed ID: 37495074
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Anxiety, Depression, Sleep Disturbance, Fibromyalgia, Obesity, and Gastroesophageal Disease in Patients with Rheumatic Diseases.
Azarfar A; Ahmed A; Bég S
Curr Rheumatol Rev; 2021; 17(2):252-257. PubMed ID: 33308134
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren's Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies.
Bucourt E; Martaillé V; Goupille P; Joncker-Vannier I; Huttenberger B; Réveillère C; Mulleman D; Courtois AR
Pain Med; 2021 Feb; 22(2):372-381. PubMed ID: 31710690
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis.
Zhao SS; Duffield SJ; Goodson NJ
Best Pract Res Clin Rheumatol; 2019 Jun; 33(3):101423. PubMed ID: 31703796
[TBL] [Abstract][Full Text] [Related]
10. The impact of concomitant fibromyalgia on visual analogue scales of pain, fatigue and function in patients with various rheumatic disorders.
Levy O; Segal R; Maslakov I; Markov A; Tishler M; Amit-Vazina M
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S120-4. PubMed ID: 27049402
[TBL] [Abstract][Full Text] [Related]
11. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents.
Infante M; Padilla N; Alejandro R; Caprio M; Della-Morte D; Fabbri A; Ricordi C
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35629988
[TBL] [Abstract][Full Text] [Related]
12. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
[TBL] [Abstract][Full Text] [Related]
13. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
14. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
Salaffi F; Gerardi MC; Atzeni F; Batticciotto A; Talotta R; Draghessi A; Di Carlo M; Sarzi-Puttini P
Rheumatol Int; 2017 Dec; 37(12):2035-2042. PubMed ID: 28875224
[TBL] [Abstract][Full Text] [Related]
15. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D
Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458
[TBL] [Abstract][Full Text] [Related]
16. [Managing comorbidities of inflammatory rheumatic diseases].
de Groot K; Märker-Hermann E
Internist (Berl); 2011 Jun; 52(6):688-96. PubMed ID: 21553073
[TBL] [Abstract][Full Text] [Related]
17. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
Sayın S; Yurdakul FG; Sivas F; Bodur H
Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
[TBL] [Abstract][Full Text] [Related]
18. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
19. Telemedicine in the Management of Patients with Rheumatic Disease during COVID-19 Pandemic: Incidence of Psychiatric Disorders and Fibromyalgia in Patients with Rheumatoid Arthritis and Psoriatic Arthritis.
Foti R; Amato G; Dal Bosco Y; Longo A; Gagliano C; Falsaperla R; Foti R; Speranza S; De Lucia F; Visalli E
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328849
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Quartuccio L; Valent F; Pasut E; Tascini C; De Vita S
Joint Bone Spine; 2020 Oct; 87(5):439-443. PubMed ID: 32445935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
